Aspira Women's Health Inc. (AWHL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 900K 1.8M 2.7M Q1 '10: 73K Q2 '10: 344K Q3 '10: 413K Q4 '10: 345K Q1 '11: 431K Q2 '11: 304K Q3 '11: 320K Q4 '11: 868K Q1 '12: 312K Q2 '12: 321K Q3 '12: 319K Q4 '12: 1.1M Q1 '13: 328K Q2 '13: 323K Q3 '13: 330K Q4 '13: 1.6M Q1 '14: 305K Q2 '14: 324K Q3 '14: 323K Q4 '14: 1.6M Q1 '15: 951K Q2 '15: 535K Q3 '15: 330K Q4 '15: 361K Q1 '16: 505K Q2 '16: 709K Q3 '16: 623K Q4 '16: 805K Q1 '17: 726K Q2 '17: 898K Q3 '17: 699K Q4 '17: 798K Q1 '18: 649K Q2 '18: 708K Q3 '18: 774K Q4 '18: 922K Q1 '19: 803K Q2 '19: 1.1M Q3 '19: 1.3M Q4 '19: 1.3M Q1 '20: 1.2M Q2 '20: 746K Q3 '20: 1.2M Q4 '20: 1.4M Q1 '21: 1.5M Q2 '21: 1.8M Q3 '21: 1.7M Q4 '21: 1.9M Q1 '22: 1.9M Q2 '22: 2.1M Q3 '22: 2.1M Q4 '22: 2.2M Q1 '23: 2.3M Q2 '23: 2.5M Q3 '23: 2.2M Q4 '23: 2.1M Q1 '24: 2.2M Q2 '24: 2.4M Q3 '24: 2.3M Q4 '24: 2.3M Q1 '25: 2.3M Q2 '25: 2.4M Q3 '25: 2.3M Q4 '25: 2.2M Q1 '26: 2M Q2 '26: 2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q1 '10: 73K Q2 '10: 332K Q3 '10: 400K Q4 '10: 282K Q1 '11: 389K Q2 '11: 267K Q3 '11: 294K Q4 '11: 844K Q1 '12: 274K Q2 '12: 293K Q3 '12: 286K Q4 '12: 1.1M Q1 '13: 291K Q2 '13: 289K Q3 '13: 305K Q4 '13: 1.5M Q1 '14: 250K Q2 '14: 236K Q3 '14: -283K Q4 '14: 1.1M Q1 '15: 460K Q2 '15: -39K Q3 '15: -427K Q4 '15: -126K Q1 '16: -23K Q2 '16: 122K Q3 '16: -194K Q4 '16: 39K Q1 '17: -1K Q2 '17: 204K Q3 '17: -80K Q4 '17: 84K Q1 '18: -154K Q2 '18: -100K Q3 '18: -4K Q4 '18: 169K Q1 '19: 109K Q2 '19: 234K Q3 '19: 336K Q4 '19: 516K Q1 '20: 420K Q2 '20: 153K Q3 '20: 432K Q4 '20: 231K Q1 '21: 603K Q2 '21: 696K Q3 '21: 749K Q4 '21: 1M Q1 '22: 961K Q2 '22: 966K Q3 '22: 1.2M Q4 '22: 1.2M Q1 '23: 1.2M Q2 '23: 1.6M Q3 '23: 1.3M Q4 '23: 1.2M Q1 '24: 1.2M Q2 '24: 1.4M Q3 '24: 1.4M Q4 '24: 1.5M Q1 '25: 1.6M Q2 '25: 1.5M Q3 '25: 1.4M Q4 '25: 1.4M Q1 '26: 1.1M Q2 '26: 1.1M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q1 '10: -3M Q2 '10: -3.7M Q3 '10: -3.6M Q4 '10: -4.3M Q1 '11: -4.4M Q2 '11: -5.6M Q3 '11: -4.5M Q4 '11: -3.1M Q1 '12: -2.2M Q2 '12: -3.7M Q3 '12: -2.3M Q4 '12: -1.3M Q1 '13: -2.6M Q2 '13: -2.1M Q3 '13: -2.3M Q4 '13: -1.8M Q1 '14: -4M Q2 '14: -5.6M Q3 '14: -5.6M Q4 '14: -4.1M Q1 '15: -4.3M Q2 '15: -4.8M Q3 '15: -5.1M Q4 '15: -5M Q1 '16: -4.9M Q2 '16: -3.8M Q3 '16: -3.5M Q4 '16: -2.8M Q1 '17: -2.7M Q2 '17: -2.3M Q3 '17: -2.5M Q4 '17: -2.9M Q1 '18: -2.8M Q2 '18: -3M Q3 '18: -2.6M Q4 '18: -2.8M Q1 '19: -3.7M Q2 '19: -4.3M Q3 '19: -3.9M Q4 '19: -3.4M Q1 '20: -3.8M Q2 '20: -3.8M Q3 '20: -4.3M Q4 '20: -6.1M Q1 '21: -5.9M Q2 '21: -8.1M Q3 '21: -9.7M Q4 '21: -8.9M Q1 '22: -9.2M Q2 '22: -8.2M Q3 '22: -8.6M Q4 '22: -5.1M Q1 '23: -6.3M Q2 '23: -4.3M Q3 '23: -4.1M Q4 '23: -4.1M Q1 '24: -4.7M Q2 '24: -4.4M Q3 '24: -3.7M Q4 '24: -3.4M Q1 '25: -3.2M Q2 '25: -1.8M Q3 '25: -1.6M Q4 '25: -1.3M Q1 '26: -2.2M Q2 '26: -1.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '10: -698K Q3 '10: -2.7M Q4 '10: -4M Q1 '11: -4.3M Q2 '11: -5.7M Q3 '11: -4.7M Q4 '11: -3.1M Q1 '12: -1.8M Q2 '12: -2M Q3 '12: -2M Q4 '12: -1.4M Q1 '13: -2.6M Q2 '13: -2.1M Q3 '13: -2.3M Q4 '13: -1.8M Q1 '14: -4M Q2 '14: -5.6M Q3 '14: -5.6M Q4 '14: -4.1M Q1 '15: -4.1M Q2 '15: -4.8M Q3 '15: -5.1M Q4 '15: -5M Q1 '16: -4.9M Q2 '16: -3.7M Q3 '16: -3.5M Q4 '16: -2.8M Q1 '17: -2.7M Q2 '17: -2.4M Q3 '17: -2.5M Q4 '17: -3M Q1 '18: -2.9M Q2 '18: -3M Q3 '18: -2.7M Q4 '18: -2.8M Q1 '19: -3.7M Q2 '19: -4.3M Q3 '19: -3.8M Q4 '19: -3.4M Q1 '20: -3.7M Q2 '20: -3.8M Q3 '20: -4.3M Q4 '20: -6.1M Q1 '21: -5.9M Q2 '21: -7.1M Q3 '21: -9.7M Q4 '21: -9M Q1 '22: -9.3M Q2 '22: -8.2M Q3 '22: -7.8M Q4 '22: -4.6M Q1 '23: -6.6M Q2 '23: -2.3M Q3 '23: -4.7M Q4 '23: -3.1M Q1 '24: -4.6M Q2 '24: -3.5M Q3 '24: -3.5M Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -2.7M Q3 '25: -4.9M Q4 '25: -3.4M Q1 '26: 676K Q2 '26: -2.4M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 500K 1M 1.5M Q2 '10: 12K Q3 '10: 13K Q4 '10: 63K Q1 '11: 42K Q2 '11: 37K Q3 '11: 26K Q4 '11: 24K Q1 '12: 38K Q2 '12: 28K Q3 '12: 33K Q4 '12: 32K Q1 '13: 37K Q2 '13: 34K Q3 '13: 25K Q4 '13: 74K Q2 '14: 88K Q3 '14: 606K Q1 '15: 491K Q2 '15: 574K Q3 '15: 757K Q4 '15: 487K Q1 '16: 528K Q2 '16: 587K Q3 '16: 817K Q4 '16: 766K Q1 '17: 727K Q2 '17: 694K Q3 '17: 779K Q4 '17: 714K Q1 '18: 803K Q2 '18: 808K Q3 '18: 778K Q4 '18: 753K Q1 '19: 694K Q2 '19: 908K Q3 '19: 949K Q4 '19: 792K Q1 '20: 800K Q2 '20: 593K Q3 '20: 807K Q4 '20: 1.2M Q1 '21: 893K Q2 '21: 1.1M Q3 '21: 917K Q4 '21: 837K Q1 '22: 932K Q2 '22: 1.1M Q3 '22: 916K Q4 '22: 913K Q1 '23: 1.1M Q2 '23: 941K Q3 '23: 910K Q4 '23: 911K Q1 '24: 939K Q2 '24: 1M Q3 '24: 902K Q4 '24: 860K Q1 '25: 719K Q2 '25: 870K Q3 '25: 922K Q4 '25: 790K Q1 '26: 896K Q2 '26: 915K Q4 '11 Q4 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '10: -3.7M Q4 '10: -2.4M Q1 '11: -2.8M Q2 '11: -3.9M Q3 '11: -4.1M Q4 '11: -4.8M Q1 '12: -2.6M Q2 '12: -3.3M Q3 '12: -2M Q4 '12: -2.4M Q1 '13: -2.2M Q2 '13: -1.7M Q3 '13: -1.8M Q4 '13: -2.5M Q1 '14: -3.5M Q2 '14: -3.7M Q3 '14: -5.3M Q4 '14: -4.2M Q1 '15: -4.5M Q2 '15: -4.9M Q3 '15: -4.3M Q4 '15: -4.6M Q1 '16: -5M Q2 '16: -3.5M Q3 '16: -2.7M Q4 '16: -2.8M Q1 '17: -2.4M Q2 '17: -1.8M Q3 '17: -1.8M Q4 '17: -2.2M Q1 '18: -2.4M Q2 '18: -2.4M Q3 '18: -2.3M Q4 '18: -2.3M Q1 '19: -3.1M Q2 '19: -3.5M Q3 '19: -3.4M Q4 '19: -2.9M Q1 '20: -3.5M Q2 '20: -3.4M Q3 '20: -3.1M Q4 '20: -4.8M Q1 '21: -5.3M Q2 '21: -6.5M Q3 '21: -8M Q4 '21: -7.6M Q1 '22: -10.2M Q2 '22: -6.3M Q3 '22: -7.5M Q4 '22: -7.1M Q1 '23: -5.7M Q2 '23: 3.4M Q3 '23: 3.3M Q4 '23: -3.5M Q1 '24: -4.4M Q2 '24: -3.7M Q3 '24: -2.9M Q4 '24: -1M Q1 '25: -3.1M Q2 '25: -1.7M Q3 '25: -212K Q4 '25: -2M Q1 '26: -359K Q2 '26: -2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '10: -3.8M Q4 '10: -2.4M Q1 '11: -2.9M Q2 '11: -4M Q3 '11: -4.1M Q4 '11: -4.8M Q1 '12: -2.6M Q2 '12: -3.3M Q3 '12: -2M Q4 '12: -2.4M Q1 '14: -3.5M Q2 '14: -3.8M Q3 '14: -5.5M Q4 '14: -4.2M Q1 '15: -4.6M Q2 '15: -5M Q3 '15: -4.4M Q4 '15: -4.6M Q1 '16: -5.6M Q2 '16: -3.9M Q3 '16: -2.9M Q4 '16: -2.8M Q1 '17: -2.4M Q2 '17: -1.8M Q3 '17: -1.8M Q4 '17: -2.2M Q1 '18: -2.4M Q2 '18: -2.4M Q3 '18: -2.3M Q4 '18: -2.4M Q1 '19: -3.2M Q2 '19: -3.6M Q3 '19: -3.5M Q4 '19: -2.9M Q1 '20: -3.5M Q2 '20: -3.5M Q3 '20: -3.2M Q4 '20: -5M Q1 '21: -5.3M Q2 '21: -6.6M Q3 '21: -8M Q4 '21: -7.7M Q1 '22: -10.3M Q2 '22: -6.3M Q3 '22: -7.6M Q4 '22: -7.2M Q1 '23: -5.7M Q2 '23: 3.4M Q3 '23: 3.3M Q4 '23: -3.5M Q1 '24: -4.5M Q2 '24: -3.8M Q3 '24: -2.9M Q4 '24: -1M Q4 '25: -2M Q4 '11 Q3 '14 Q2 '16 Q1 '18 Q4 '19 Q3 '21 Q2 '23 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '21: 112M Q3 '21: 112.1M Q1 '22: 7.5M Q2 '22: 7.5M Q3 '22: 7.8M Q1 '23: 8.3M Q2 '23: 8.4M Q3 '23: 9.8M Q1 '24: 11.8M Q2 '24: 12.5M Q3 '24: 15.4M Q1 '25: 21.6M Q2 '25: 35.6M Q3 '25: 36.4M Q1 '26: 45.8M Q2 '26: 44.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q1 '11: -1.05 Q2 '11: -1.37 Q3 '11: -1.42 Q4 '11: -1.25 Q1 '12: -1.03 Q2 '12: -0.77 Q3 '12: -0.59 Q4 '12: -0.47 Q1 '13: -0.52 Q2 '13: -0.50 Q3 '13: -0.47 Q4 '13: -0.44 Q1 '14: -0.38 Q2 '14: -0.42 Q3 '14: -0.48 Q4 '14: -0.53 Q1 '15: -0.52 Q2 '15: -0.48 Q3 '15: -0.42 Q4 '15: -0.41 Q1 '16: -0.40 Q2 '16: -0.36 Q3 '16: -0.33 Q4 '16: -0.29 Q1 '17: -0.25 Q2 '17: -0.22 Q3 '17: -0.21 Q4 '17: -0.20 Q1 '18: -0.20 Q2 '18: -0.20 Q3 '18: -0.18 Q4 '18: -0.16 Q1 '19: -0.16 Q2 '19: -0.18 Q3 '19: -0.18 Q4 '19: -0.19 Q1 '20: -0.18 Q2 '20: -0.16 Q3 '20: -0.16 Q4 '20: -0.18 Q1 '21: -0.19 Q2 '21: -0.21 Q3 '21: -0.26 Q4 '21: -4.27 Q1 '22: -5.46 Q2 '22: -6.50 Q3 '22: -7.41 Q4 '22: -3.86 Q1 '23: -3.41 Q2 '23: -2.59 Q3 '23: -2.07 Q4 '23: -1.82 Q1 '24: -1.42 Q2 '24: -1.42 Q3 '24: -1.17 Q4 '24: -0.95 Q1 '25: -0.65 Q2 '25: -0.44 Q3 '25: -0.34 Q4 '25: -0.36 Q4 '11 Q4 '13 Q4 '15 Q4 '17 Q4 '19 Q4 '21 Q4 '23 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.